BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28

• Business

  Novocure’s General Counsel Resigns After 10 Years of Service

  Novocure announced that Todd Longsworth, General Counsel, has resigned. Mr. Longsworth’s last day as General Counsel will be March 31.

  February 24, 2022

   · 

  3 min read
• Business

  DBV Technologies to Report Full Year 2021 Financial Results and Business Updates on March 3, 2022

  DBV Technologies, a clinical-stage biopharmaceutical company, announced that the Company will host a conference call and live audio webcast on Thursday, March 3, 2022 at 5:00 p.m. ET to report full year 2021 financial results and provide a corporate update.

  February 24, 2022

   · 

  1 min read
• Business

  Cellectis to Hold Fourth Quarter 2021 Earnings Call on Friday March 4, 2022 at 8:00AM EST

  Cellectis announced that it will report its financial results for the fourth quarter and year-end 2021 ending December 31, 2021, on Thursday, March 3, 2022, after the close of the US market.

  February 24, 2022

   · 

  4 min read
• Business

  Centene Announces Approval of Request By Michael Neidorff, Chairman & CEO, To Take A Medical Leave Of Absence

  Centene Corporation announced that its Board of Directors approved a request from Michael Neidorff, Chairman & Chief Executive Officer, for a medical leave of absence.

  February 24, 2022

   · 

  9 min read
• Business

  Vericel Announces Appointment of Jonathan Siegal as Principal Accounting Officer

  Vericel Corporation, a leader in advanced therapies for the sports medicine and severe burn care markets, announced that the Board of Directors has appointed Jonathan Siegal as the Company’s Principal Accounting Officer, effective February 16, 2022.

  February 24, 2022

   · 

  2 min read
• Lone Star Bio

  4WEB Medical Launches Hyperlordotic Lateral Implant Portfolio

  4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design utilizing its proprietary Truss Implant Technology™, announced the company’s launch of a comprehensive array of hyperlordotic lateral implants.

  February 24, 2022

   · 

  2 min read
• Business

  Operational Highlights and Financial Results for the Period Ended December 31, 2021Mesoblast Prepares for Resubmission of Biologics License Application

  Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reported financial results and operational highlights for the period ended December 31, 2021.

  February 24, 2022

   · 

  27 min read
• Deals

  Ecolab Declares Regular Dividend

  The board of directors of Ecolab Inc. today declared a regular quarterly cash dividend of $0.51 per common share, to be paid April 15, 2022, to shareholders of record at the close of business on March 15, 2022.

  February 24, 2022

   · 

  1 min read
• Biotech Bay

  Accuray to Participate in the Cowen 42nd Annual Health Care Conference

  Accuray Incorporated announced its participation in the Cowen 42nd Annual Health Care Conference taking place March 7-9, 2022.

  February 24, 2022

   · 

  1 min read
• Business

  Neovasc to Report Fourth Quarter and Full Year 2021 Financial Results on March 10, 2022

  Neovasc Inc. ( NASDAQ , TSX : NVCN), will report financial results for the quarter and full year ended December 31, 2021 on Thursday, March 10, 2022.

  February 24, 2022

   · 

  1 min read